Upcoming RSNA conference to unveil revolutionary Merge technology
Written by Alyssa Clark
There is a gap in the healthcare market surrounding the lack of imaging technology and the ability to easily share healthcare related images. Image sharing and image viewing has been a long-contemplated issue within the healthcare field, especially since the revolutionary way of reinterpreting records and sharing of EHR, and now we have companies and patients demanding a better way to access and share health-related images.
"Based on client feedback and changing clinical, IT and business requirements, Merge has developed three flexible configurations of iConnect Access that can meet all institutions' specific mission and workflows," said Justin Dearborn, CEO of Merge. "Merge is the only vendor to offer this unique and innovative combination of image sharing and enterprise viewing...no third-parties, no partners. This is our true end-to-end enterprise imaging solution and we are pleased to show it at RSNA this year."
The radiology division of the healthcare world specifically has been hit hard by the lack of image sharing technology— but healthcare professionals need no longer worry, since Merge Solutions brings image viewing to center stage, finally.
Dealing with the issues of remote locations, decreased availability of expensive machines and equipment, the ability of sharing data between image viewing machines and the different business models and expenditures of corporations, Merge has identified all of these market flaws and has capitalized immensely on them. Merge will introduce its iConnect Access Version 5.0 at the RSNA Conference on December 1st-6th, in Chicago Illinois. As an industry-first, this technology will display the enterprise of image sharing technology that integrates seamlessly into the already standing EHR technology.
Slated for delivery in the first quarter of 2014, iConnect Access 5.0 is part of the iConnect Enterprise Clinical Platform and includes iConnect Enterprise Archive, which was ranked the largest vendor-neutral archive in the world for the second year in a row by IHS. This universal viewer solution will be the main event, as it is highly-anticipated throughout the healthcare industry, and looks to be the next up-and-coming investment opportunity for start-up investors everywhere.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”